InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
4
T+90 hit rate
33%
T+90 mean return
-14.8%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Behbahani Ali, Director. Director active across 19 companies, notably Oyster Point Pharma, Inc.. Cumulatively, 53 filings have been logged. Split: 4 buys · 4 sells. Total volume traded: €10.3m. History available since 7 June 2021. The latest transaction was filed on 1 July 2026 (J). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Behbahani Ali
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations53 total
1,000,000 shares0Common StockSEC:0001193125-26-296490:0
15,000 shares0Common StockSEC:0001193125-26-296490:1
15,000 shares0Common StockSEC:0001193125-26-296490:2
8,961 sharesCommon StockSEC:0001193125-26-277553:0
1,925 sharesCommon StockSEC:0001193125-26-187305:0
2,706 sharesCommon StockSEC:0001193125-26-187305:1
6,919 shares@ US$2.150.3% of flowCommon StockSEC:0001193125-26-117938:0
207,100 shares@ US$11.1167.8% of flowCommon StockSEC:0001193125-26-104718:0
1,619,240 sharesCommon StockSEC:0001193125-26-046676:0
5,208 shares@ US$2.760.3% of flowCommon StockSEC:0001193125-25-319303:0
189,195 shares@ US$0.01100.0% of flowCommon StockSEC:0001193125-25-232141:0
4,291 shares@ US$3.350.3% of flowCommon StockSEC:0001193125-25-211678:0
4,828,206 shares@ US$0.01123.2% of flowOrdinary Shares with a nominal value of 0.001 GBP per shareSEC:0000950170-25-110254:0
14,671,794 shares@ US$0.01276.8% of flowOrdinary Shares with a nominal value of 0.001 GBP per shareSEC:0000950170-25-110254:1
1,586 shares0Common StockSEC:0000950170-25-109112:0
6,170 shares@ US$2.330.3% of flowCommon StockSEC:0000950170-25-088527:0
7,646 shares@ US$1.880.3% of flowCommon StockSEC:0000950170-25-043221:0
5,750 shares@ US$2.500.3% of flowCommon StockSEC:0000950170-24-136739:0
3,007 shares@ US$4.780.3% of flowCommon StockSEC:0000950170-24-108430:0
1,023,103 sharesCommon StockSEC:0000950170-24-107554:0
2,887 shares@ US$4.980.3% of flowCommon StockSEC:0000950170-24-076273:0
17,857 shares@ US$56.00100.0% of flowCommon StockSEC:0000950170-24-047684:0
3,166 shares@ US$4.540.3% of flowCommon StockSEC:0000950170-24-041554:0
316 shares@ US$0.237100.0% of flowCommon StockSEC:0001209191-23-058968:0
4,455 shares@ US$2.730.2% of flowCommon StockSEC:0001209191-23-058790:0
25 of 53 declarations
About Behbahani Ali
Behbahani Ali is Administrateur and has filed 53 filings in total. Across the 53 sampled recent filings, reported buys amount to EUR 10091818 and reported sells to EUR 240418, covering the period from 2021-06-09 to 2026-07-06. The recent filings relate to Black Diamond Therapeutics, Inc., Arcellx, Inc., Monte Rosa Therapeutics, Inc., Korro Bio, Inc., Oyster Point Pharma, Inc. and Adaptimmune Therapeutics PLC.
